Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Net Cash Flow (2022 - 2025)

Historic Net Cash Flow for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to -$1.6 million.

  • Neuraxis' Net Cash Flow fell 710.97% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 92264.59%. This contributed to the annual value of $3.6 million for FY2024, which is 216596.47% up from last year.
  • As of Q3 2025, Neuraxis' Net Cash Flow stood at -$1.6 million, which was down 710.97% from $4.0 million recorded in Q2 2025.
  • Neuraxis' Net Cash Flow's 5-year high stood at $4.0 million during Q2 2025, with a 5-year trough of -$1.7 million in Q1 2025.
  • In the last 4 years, Neuraxis' Net Cash Flow had a median value of $3192.0 in 2024 and averaged $331035.6.
  • As far as peak fluctuations go, Neuraxis' Net Cash Flow skyrocketed by 2806667.22% in 2024, and later tumbled by 5309185.46% in 2025.
  • Quarter analysis of 4 years shows Neuraxis' Net Cash Flow stood at $245879.0 in 2022, then plummeted by 377.65% to -$682689.0 in 2023, then surged by 603.3% to $3.4 million in 2024, then crashed by 146.9% to -$1.6 million in 2025.
  • Its last three reported values are -$1.6 million in Q3 2025, $4.0 million for Q2 2025, and -$1.7 million during Q1 2025.